NOVARTIS AG (NVSEF)
Clinical trial NCT05843253: enrollment: not set → 120 participants.
Clinical trial NCT05843253: enrollment: not set → 120 participants.
Clinical trial NCT04983030 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-04-30 → 2026-02-23 3. primary completion date: 2026-02-28 → 2026-02-23 4. enrollment: not set → 28 participants
Clinical trial NCT06948435 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. enrollment: not set → 487 participants
Clinical trial NCT07543055 updates: 1. start date: 2026-05-14 → 2026-06-01 2. completion date: 2030-11-04 → 2031-03-20 3. primary completion date: 2029-12-13 → 2029-12-31 4. enrollment: not set → 36 participants
Clinical trial NCT06769659 updates: 1. completion date: 2026-05-30 → 2026-10-30 2. primary completion date: 2026-03-30 → 2026-08-30 3. enrollment: not set → 12 participants
Clinical trial NCT05147220 updates: 1. primary completion date: 2026-04-30 → 2026-07-23 2. enrollment: not set → 1000 participants
Clinical trial NCT07325292: enrollment: not set → 160 participants.
Clinical trial NCT06153667: enrollment: not set → 100 participants.
Clinical trial NCT07492680: enrollment: not set → 260 participants.
Clinical trial NCT07184931: enrollment: not set → 980 participants.